These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 9524537)

  • 1. [Vascular endothelial growth factor VEGF stimulates angiogenesis in good and bad situations].
    Heits F; Wiedemann GJ; Jelkmann W
    Dtsch Med Wochenschr; 1998 Feb; 123(9):259-65. PubMed ID: 9524537
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
    Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review.
    Amoroso A; Del Porto F; Di Monaco C; Manfredini P; Afeltra A
    Eur Rev Med Pharmacol Sci; 1997; 1(1-3):17-25. PubMed ID: 9444794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF).
    Baumgartner I; Isner JM
    Vasa; 1998 Nov; 27(4):201-6. PubMed ID: 9859738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of angiogenic growth factors and their inhibitors.
    Ferrara N; Alitalo K
    Nat Med; 1999 Dec; 5(12):1359-64. PubMed ID: 10581076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G
    Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor: molecular and biological aspects.
    Ferrara N
    Curr Top Microbiol Immunol; 1999; 237():1-30. PubMed ID: 9893343
    [No Abstract]   [Full Text] [Related]  

  • 8. [VEGF in therapeutic coronary and peripheral artery angiogenesis].
    Elbaz M; Malavaud B
    Pathol Biol (Paris); 1999 Apr; 47(4):380-4. PubMed ID: 10372409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients?
    Gröne HJ
    Nephrol Dial Transplant; 1995; 10(6):761-3. PubMed ID: 7566598
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.
    Isner JM; Asahara T
    J Clin Invest; 1999 May; 103(9):1231-6. PubMed ID: 10225965
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis update].
    Vandenbunder B
    Bull Cancer; 1999 Jan; 86(1):29-36. PubMed ID: 10029701
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid-induced angiogenesis is VEGF-dependent.
    Carter WB; Uy K; Ward MD; Hoying JB
    Surgery; 2000 Sep; 128(3):458-64. PubMed ID: 10965318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.